Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Regulatory Approval

Pune E-Stock Broking Regulatory Approval

Pune E-Stock Broking's subsidiary, Pune Finvest, received IRDAI approval to act as a Corporate Agent. This license enables the group to expand into composite insurance distribution.

Source

BSE filing, BSE: 544141. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Pune E-Stock Broking Ltd: key numbers

Share price
₹261.00
Market cap
₹408.5 Cr
Revenue (annual)
₹53.87 Cr
Net profit (annual)
₹19.56 Cr
P/E (TTM)
20.9×Sector 19.7×
Promoter holding
50.79%
FII holding
0.49%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Pune E-Stock Broking Ltd

All →
12:54 IST BSE
Fund Raise

Pune E-Stock Broking Fund Raise of ₹50 Cr

Pune E-Stock Broking Limited's board has approved raising up to ₹50 Crore through the issuance of Non-Convertible Debentures (NCDs). The secured debt will be issued on a private placement basis.

Value
₹50.00 Cr
Execution
within a period of one year from the date of passing of the relevant Board Resolution

Other regulatory approval announcements

All →
18:40 IST NSE
Regulatory ApprovalShalby Ltd SHALBY

Shalby Regulatory Approval

Shalby Hospital, Jabalpur received CMHO permission to resume normal operations, including patient admissions, on its previously affected floor. The hospital has now fully resumed healthcare services.

23:24 IST BSE
Regulatory ApprovalElantas Beck India Ltd ELANTAS

Elantas Beck India Regulatory Approval

Elantas Beck India's GPCB permanently revoked the closure direction on its Ankleshwar plant. The facility can keep operating, subject to compliance conditions.

20:11 IST BSE
Regulatory ApprovalKalyani Cast-Tech Ltd 544023

Kalyani Cast-Tech Regulatory Approval

Kalyani Cast-Tech received RDSO Stage-I concept design approval for its new container-carrying wagon under PWDA. Stage-II detailed design approval is still required, subject to dynamics simulation conditions.

17:46 IST BSE
Regulatory ApprovalMukka Proteins Ltd MUKKA

Mukka Proteins Regulatory Approval

Mukka Proteins received a US FDA facility registration certificate, valid October 1, 2026 to December 31, 2027. The company says the registration supports its engagement with US customers and markets.

Execution
October 1, 2026 to December 31, 2027
16:14 IST BSE
Regulatory ApprovalCanara Bank CANBK

Canara Bank Regulatory Approval

Canara Bank received RBI permission to exercise the call option on its Basel III AT1 bonds (ISIN INE476A08134) of Rs.1,500 Crore. The bank is now in process of exercising the call as per the issue terms.

Value
₹1,500 Cr
15:29 IST BSE
Regulatory ApprovalAlembic Pharmaceuticals Ltd APLLTD

Alembic Pharmaceuticals Regulatory Approval

Alembic Pharmaceuticals received USFDA final approval for Valganciclovir for Oral Solution, 50 mg/mL. This adds to its cumulative 247 USFDA ANDA approvals.